Evidence of Long-Term Suppression of Hepatitis B virus DNA by Tenofovir as Rescue Treatment in Patients Coinfected by HIV
暂无分享,去创建一个
C. Torti | G. Carosi | M. Puoti | E. Quiros-Roldan | G. Lapadula | S. Costarelli | G. Cologni | S. Zaltron | V. Tirelli | A. Calabresi
[1] Lin Shen,et al. The HBV drug entecavir - effects on HIV-1 replication and resistance. , 2007, The New England journal of medicine.
[2] M. Peters,et al. Viral hepatitis in HIV infection. , 2007, The New England journal of medicine.
[3] William M. Lee,et al. Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] P. Kipnis,et al. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV‐coinfected patients: factors associated with response , 2007, Journal of viral hepatitis.
[5] R. Bruno,et al. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection , 2006, AIDS.
[6] J. Villeneuve,et al. Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient. , 2006, Gastroenterology.
[7] M. Helm,et al. Variant of hepatitis B virus with primary resistance to adefovir. , 2006, The New England journal of medicine.
[8] S. Lewin,et al. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy , 2006, AIDS.
[9] Angeline Bartholomeusz,et al. HBV drug resistance: mechanisms, detection and interpretation. , 2006, Journal of hepatology.
[10] C. Katlama,et al. Anti‐hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV‐infected patients , 2006, Hepatology.
[11] A. Valleron,et al. Long-term hepatitis B virus dynamics in HIV–hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate , 2005, AIDS.
[12] S. Lewin,et al. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV–HBV co-infected individuals , 2003, AIDS.
[13] Robin Patel,et al. Characterization of Hepatitis B Virus Surface Antigen and Polymerase Mutations in Liver Transplant Recipients Pre‐ and Post‐Transplant , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] P. Tebas,et al. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed. , 2002, The Journal of infectious diseases.
[15] J. Torresi. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[16] R. D. de Man,et al. Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[17] D. Jackson,et al. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. , 2002, Virology.
[18] Y. S. Kim,et al. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. , 2001, Journal of Korean medical science.